KC1036 not checked
Beijing Konruns Pharmaceutical Co., Ltd.
FollowEvery change as it happens, and a Monday email
Trials
3 active
6 in total
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “KC1036 60mg QD orally, before a meal, continuous administration, 21 days as a cycle”In the company’s words, NCT06194734 on ClinicalTrials.gov
- Tested for
- Esophageal Squamous Cell Carcinoma, Ewing Sarcoma, Esophageal Squamous Cell Carcinoma (ESCC)
- Main trialPhase 3
- “The purpose of this study is to evaluate the efficacy and safety of KC1036 versus investigator's choice of chemotherapy in patients with advanced recurrent or metastatic esophageal squamous cell carcinoma”In the company’s words, NCT06194734 on ClinicalTrials.gov
Other drugs for Esophageal Squamous Cell Carcinoma
- DurvalumabAstraZeneca · Phase 3
- Ifinatamab DeruxtecanDaiichi Sankyo · Phase 3
- MHB088CQilu Pharmaceutical · Phase 3
- Izalontamab brengitecanSichuan Baili (Biokin, SystImmune) · Bristol Myers Squibb · Phase 3
- EnlonstobartCSPC · Phase 3
- SYS6010CSPC · Phase 3
Coming up3
- 30 DecPhase 3 trial completes · ClinicalTrials.gov
- 1 Apr 2027Phase 2 trial completes · ClinicalTrials.gov
- Dec 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 30 Dec 2026 | A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer | |
| Phase 2Recruiting | 1 Apr 2027 | A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma | |
| Phase 2Recruiting | Dec 2027 | KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer | |
| Phase 2Unknown | Feb 2025 | A Study of KC1036 in Patients with Advanced Thymic Tumors | |
| Phase 1/2Unknown | 30 Oct 2025 | To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors | |
| Phase 1Unknown | 31 Oct 2025 | A Study of KC1036 in Patients with Advanced Solid Tumors |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026